Vaso Corp (VASO) — 10-Q Filings

All 10-Q filings from Vaso Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

  • VASO Swings to Profit on Strong Sales, Cuts Transaction Costs — Nov 14, 2025 Risk: medium
    VASO Corp reported a significant turnaround for the three months ended September 30, 2025, achieving a net income of $1.711 million, a substantial improvement f
  • VASO Corp's Net Loss Widens Amid Rising Operating Costs — Aug 14, 2025 Risk: high
    VASO Corp reported a net loss of $1.272 million for the six months ended June 30, 2025, a significant decline from a net loss of $18,000 in the same period of 2
  • VASO Corp Files Q1 2025 10-Q Report — May 15, 2025 Risk: low
    VASO Corp filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as Vasomedical, Inc., is incorporated in Dela
  • VASO Corp Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: low
    VASO Corp filed its quarterly report on Form 10-Q for the period ending September 30, 2024. The company, formerly known as Vasomedical, Inc., is incorporated in
  • VASO Corp Files Q2 2024 10-Q Report — Aug 14, 2024 Risk: low
    VASO Corporation filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as Vasomedical, Inc., is incorporated in Delaware and
  • VASO Corp Files 10-Q for Period Ended March 31, 2024 — May 15, 2024 Risk:
    VASO Corp (VASO) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. VASO Corp filed a 10-Q report for the quarterly period ended March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.